25 LLC’s Pactiv Evergreen Inc. Common stock PTVE Stock Holding History

25 LLC’s Portfolio PTVE Stock Details PTVE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-61	Closed	-$435	–	710
2023 Q1	$435	Buy	+61	New	+$627	﹤0.01%	468

Other funds holding PTVE

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EVR Research Richmond, Virginia $250M AUM 41.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

25 LLC's PTVE Position: Q2 2023 in Review

25 LLC sold out of Pactiv Evergreen Inc. Common stock (PTVE) in Q2 2023, closing a stake of 61 shares — an estimated $435 sold.

25 LLC first reported a position in PTVE in Q1 2023 and held it in 1 quarter. The position peaked at $435 in Q1 2023. 122 funds tracked by Wall St. Rank hold PTVE as of Q2 2023.

25 LLC reported no remaining Pactiv Evergreen Inc. Common stock position as of Q2 2023 after selling out during the quarter.
25 LLC sold 61 Pactiv Evergreen Inc. Common stock shares in Q2 2023, an estimated $435.
25 LLC first reported a position in Pactiv Evergreen Inc. Common stock in Q1 2023 and held it in 1 quarter.
25 LLC's Pactiv Evergreen Inc. Common stock position peaked at $435 in Q1 2023.
122 funds tracked by Wall St. Rank held Pactiv Evergreen Inc. Common stock as of Q2 2023.

Based on 25 LLC's 13F filing for Q2 2023, filed 19 Jul 2023.